English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Stanford University School Of Medicine
Mia Sims
| Jul 17, 2017
Study indicates ibuprofen a risk for marathon runners
Amanda Rupp
| Jun 29, 2016
Atrial flutter patients receive updated performance, quality measures
Trending
+
Pharmaceuticals
Patient Daily
| Jun 23, 2025
PhRMA says patients in the U.S. face higher prescription costs due to 340B program
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’
+
Pharmaceuticals
Patient Daily
| Jun 25, 2025
Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+
Pharmaceuticals
Patient Daily
| Jun 19, 2025
FDA loophole lets low-quality drugs from China and India flood U.S. market, while American manufacturers are held to higher standards